Survival and functional status after resection of recurrent glioblastoma multiforme

Neurosurgery

Volumn 42, Issue 4, 1998, Pages 709-723

  Barker II, Fred C ^b   Chang, Susan M ^a   Gutin, Philip H ^a   Malec, Mary K ^a   McDermott, Michael W ^a   Prados, Michael D ^a   Wilson, Charles B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Glioblastoma multiforme; Karnofsky performance score; Prognostic factors; Reoperation

Indexed keywords

CARMUSTINE; EFLORNITHINE; HYDROXYUREA; TIOGUANINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; FUNCTIONAL ASSESSMENT; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOSURGERY; REOPERATION; RETROSPECTIVE STUDY; STEREOTAXIC SURGERY; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; REOPERATION; STATISTICS; SURVIVAL ANALYSIS;

EID: 0031970420     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199804000-00013     Document Type: Article

References (66)

1. Ammirati M, Galicich JH, Arbit E, Liao Y: Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21:607-614, 1987.
2. Barker FG II: Analysis of the relationship between long-term operative success and a transient or delayed operative side effect. Neurosurgery 39:412-416, 1996.
3. Barker FG II, Chang SM, Larson DA, Sneed PK, Lamborn KR, Gutin PH, McDermott MW, Prados MD: Age and radiation response in glioblastoma multiforme. J Neurooncol 28:64, 1996 (abstr).
4. Barker FG II, Chang SM, Valk PE, Pounds TR, Prados MD: 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer 79:115-126, 1997.
5. Barker FG II, Davis RL, Chang SM, Prados MD: Necrosis as a prognostic factor in glioblastoma multiforme. Cancer 77:1161-1166, 1996.
6. Barker FG II, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, Malec MK, McDermott MW, Sneed PK, Wara WM, Wilson CB: Radiation response and survival in patients with glioblastoma multiforme. J Neurosurg 84:442-448, 1996.
7. Begg CB, Engstrom PF: Eligibility and extrapolation in cancer clinical trials. J Clin Oncol 5:962-968, 1987.
8. Bentzen SM, Vaeth M, Pedersen DE, Overgaard J: Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment. . . now! Int J Radiat Oncol Biol Phys 32:1531-1534, 1995.
9. Berger MS, Tucker A, Spence A, Winn HR: Reoperation for glioma. Clin Neurosurg 39:172-186, 1992.
10. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisri M, Brem M, Mohr G, Muller P, Morawetz R, Schold SC, and the Polymer-Brain Tumor Study Group: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345:1008-1012, 1995.
11. Connors AF Jr, Speroff T, Dawson NV, Thomas C, Harrell FE Jr, Wagner D, Desbiens N, Goldman L, Wu AW, Califf RM, Fulkerson WJ Jr, Vidaillet H, Broste S, Bellamy P, Lynn J, Knaus WA, and the SUPPORT Investigators: The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276:889-897, 1996.
12. Curran WJ Jr, Scott CB, Weinstein AS, Martin LA, Nelson JS, Phillips TL, Murray K, Fischbach AJ, Yakar D, Schwade JG, Corn B, Nelson DF: Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: A report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 11:857-862, 1993.
13. Cushing H: Intracranial Tumours. Springfield, Charles C Thomas, 1932.
14. Davis RL: Grading of gliomas, in Fields WS (ed): Primary Brain Tumors: A Review of Histologic Classification. New York, Springer-Verlag, 1989, pp 150-158.
15. Davis RL, Liu HC, Vestnys P, Resser KJ, Levin VA: Correlation of survival and diagnosis in supratentorial malignant gliomas. J Neurooncol 2:267, 1984 (abstr).
16. Davis L, Martin J, Goldstein SL, Askenazy M: A study of 211 patients with verified glioblastoma multiforme. J Neurosurg 6:33-44, 1949.
17. Dirks P, Bernstein M, Muller PJ, Tucker WS: The value of reoperation for recurrent glioblastoma. Can J Surg 36:271-275, 1993.
18. Durmaz R, Erken S, Arslantas A, Atasoy MA, Bal C, Tel E: Management of glioblastoma multiforme: With special reference to recurrence. Clin Neurol Neurosurg 99:117-123, 1997.
19. Florell RC, Macdonald DR, Irish WD, Bernstein M, Leibel SA, Gutin PH, Cairncross JG: Selection bias, survival, and brachytherapy for glioma. J Neurosurg 76:179-183, 1992.
20. Frankel SA, German WJ: Glioblastoma multiforme: Review of 219 cases with regard to natural history, pathology, diagnostic methods, and treatment. J Neurosurg 15:489-503, 1958.
21. George SL: Reducing patient eligibility criteria in cancer clinical trials. J Clin Oncol 14:1364-1370, 1996.
22. Giovagnoli AR, Boiardi A: Cognitive impairment and quality of life in long-term survivors of malignant brain tumors. Ital J Neurol Sci 15:481-488, 1994.
23. Giovagnoli AR, Tamburini M, Boiardi A: Quality of life in brain tumor patients. J Neurooncol 30:71-80, 1996.
24. Glesby MJ, Hoover DR: Survivor treatment selection bias in observational studies: Examples from the AIDS literature. Ann Intern Med 124:999-1005, 1996.
25. Hall WA, Djalilian HR, Sperduto PW, Cho KH, Gerbi BJ, Gibbons JP, Rohr M, Clark HB: Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13:1642-1648, 1995.
26. Halperin EC, Herndon J, Schold SC Jr, Brown M, Vick N, Cairncross JG, Macdonald DR, Gaspar L, Fischer B, Dropcho E, Rosenfeld S, Morowitz R, Piepmeier J, Hait W, Byrne T, Salter M, Imperato J, Khandekar J, Paleologos N, Burger P, Bentel GC, Friedman A, for the CNS Cancer Consortium: A Phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with malignant glioma of the brain. Int J Radiat Oncol Biol Phys 34:793-802, 1996.
27. Harsh GR IV, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21:615-621, 1987.
28. Hosmer DW Jr, Lemeshow S: Applied Logistic Regression. New York, John Wiley & Sons, 1989.
29. Kaye AH: Malignant brain tumors, in Little JR, Awad IA (eds): Reoperative Neurosurgery. Baltimore, Williams & Wilkins, 1992, pp 51-76.
30. Kaye AH: Re-operation for recurrent malignant brain rumours: Is it worthwhile? Aust N Z J Surg 62:677-679, 1992.
31. Kirby S, Brothers M, Irish W, Florell R, Macdonald D, Schold C, Cairncross G: Evaluating glioma therapies: Modeling treatments and predicting outcomes. J Natl Cancer Inst 87:1884-1888, 1995.
32. Klatzmann D, Philippon J, Valery CA, Bensimon G, Salzmann J-L: Gene therapy for glioblastoma in adult patients: Safety and efficacy evaluation of an in situ injection of recombinant retrovirus-producing cells carrying the thymidine kinase gene of the herpes simplex Type 1 virus, to be followed with the administration of ganciclovir. Hum Gene Ther 7:109-126, 1996.
33. Kleihues P, Burger PC, Scheithauer BW: Histologic Typing of Tumours of the Central Nervous System. Berlin, Springer-Verlag, 1993, ed 2.
34. Krouwer HGJ, Prados MD: Infiltrative astrocytomas of the thalamus. J Neurosurg 82:548-557, 1995.
35. Landy HJ, Feun L, Schwade JG, Snodgrass S, Lu Y, Gutman F: Retreatment of intracranial gliomas. South Med J 87:211-214, 1994.
36. Lee ET: Statistical Methods for Survival Data Analysis. New York, John Wiley & Sons, 1992, ed 2.
37. Machin D, Gardner MJ: Calculating confidence intervals for survival time analyses, in Gardner MJ, Altman DG (eds): Statistics with Confidence. London, British Medical Journal, 1989, pp 64-70.
38. Mahaley MS, Mettlin C, Natarajan N, Laws ER Jr, Peace BB: National survey of patterns of care for brain-tumor patients. J Neurosurg 71:826-836, 1989.
39. Marubini E, Mariani L, Salvadori B, Veronesi U, Saccozzi R, Merson M, Zucali R, Rilke F: Results of a breast-cancer-surgery trial compared with observational data from routine practice. Lancet 347:1000-1003, 1996.
40. Massey V, Wallner KE: Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys 18:395-398, 1990.
41. Moser RP: Surgery for glioma relapse: Factors that influence a favorable outcome. Cancer 62:381-390, 1988.
42. Popovic EA, Kaye AH, Hill JS: Photodynamic therapy of brain tumors. Semin Surg Oncol 11:335-345, 1995.
43. Rosenbaum PR: Observational Studies. New York, Springer-Verlag, 1995.
44. Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 70: 41-55, 1983.
45. Rosenbaum PR, Rubin DB: Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79:516-524, 1984.
46. Rostomily RC, Spence AM, Duong D, McCormick K, Bland M, Berger MS: Multimodality management of recurrent adult malignant gliomas: Results of a Phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery 35: 378-388, 1994.
47. Roth JG, Elvidge AR: Glioblastoma multiforme: A clinical survey. J Neurosurg 17:736-750, 1960.
48. Salcman M: Surgical resection of brain tumors: Who benefits? Oncology 2:47-57, 1988.
49. Salcman M, Kaplan RS, Ducker TB, Abdo H, Montgomery E: Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma. Neurosurgery 10:454-463, 1982.
50. Salcman M, Scholtz H, Kaplan RS, Kulik S: Long-term survival in patients with malignant astrocytoma. Neurosurgery 34:213-220, 1994.
51. Scharfen CO, Sneed PK, Wara WM, Larson DA, Phillips TL, Prados MD, Weaver KA, Malec M, Acord P, Lamborn KR, Lamb SA, Ham B, Gutin PH: High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 24:583-591, 1992.
52. Shepard SR, McDermott MW, Sneed PK, Larson DA, Prados MD, Gutin PH: Complications and results of craniotomy for radiation necrosis following interstitial brachytherapy. Can J Neurol Sci 21[Suppl 2]:S3, 1994 (abstr).
53. Shrieve DC, Alexander E III, Wen PY, Fine HA, Kooy HM, Black PMcL, Loeffler JS: Comparison of stereotactic radiosurgery and brachvtherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36:275-284, 1995.
54. Simon R: Confidence intervals for reporting results of clinical trials. Ann Intern Med 105:429-435, 1986.
55. Sipos L, Áfra D: Re-operations of supratentorial anaplastic astrocytomas. Acta Neurochir (Wien) 139:99-104, 1997.
56. Sprent P: Applied Nonparametric Statistical Methods. London, Chapman & Hall, 1993, ed 2.
57. Stone RA, Obrosky DS, Singer DE, Kapoor WN, Fine MJ, and the Pneumonia Patient Outcomes Research Team (PORT) Investigators: Propensity score adjustment for pretreatment differences between hospitalized and ambulatory patients with community-acquired pneumonia. Med Care 33:AS56-AS66, 1995.
58. Strodie;mblad L-G, Anderson H, Malmström P, Salford LG: Reoperation for malignant astrocytomas: Personal experience and a review of the literature. Br J Neurosurg 7:623-633, 1993.
59. Turnbull BW: The empirical distribution function with arbitrarily grouped, censored and truncated data. J R Stat Soc B 38:290-295, 1976.
60. Vick NA, Ciric IS, Eller TW, Cozzens JW, Walsh A: Reoperation for malignant astrocytoma. Neurology 39:430-432, 1989.
61. Wallner KE, Galicich JH, Malkin MG, Arbit E, Krol G, Rosenblum MK: Inability of computed tomography appearance of recurrent malignant astrocytoma to predict survival following reoperation. J Clin Oncol 7:1492-1496, 1989.
62. Wharen RE, Anderson RE, Laws ER Jr: Photoradiation therapy of brain tumors, in Salcman M (ed): Neurobiology of Brain Tumors. Baltimore, Williams & Wilkins, 1991, pp 341-357.
63. Winger MJ, Macdonald DR, Schold SC Jr, Cairncross JG: Selection bias in clinical trials of anaplastic glioma. Ann Neurol 26:531-534, 1989.
64. Wolfe RA, Strawderman RL: Logical and statistical fallacies in the use of Cox regression models. Am J Kidney Dis 27:124-129, 1996.
65. Yaes RJ: Tumor heterogeneity, tumor size, and radioresistance. Int J Radiat Oncol Biol Phys 17:993-1005, 1989.
66. Young B, Oldfield EH, Markesbery WR, Haack D, Tibbs PA, McCombs P, Chin HW, Maruyama Y, Meacham WF: Reoperation for glioblastoma. J Neurosurg 55:917-921, 1981.